✦ LIBER ✦

Spontaneous reporting of adverse reactions to psychiatric drugs

✍ Scribed by Rassaby, Elaine; Medawar, Charles

Book ID: 122843730
Publisher: The Lancet
Year: 1992
Tongue: English
Weight: 175 KB
Volume: 339
Category: Article
ISSN: 0140-6736
DOI: 10.1016/0140-6736(92)90833-O

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Spontaneous reporting of adverse drug re

Spontaneous reporting of adverse drug reactions to non-steroidal anti-inflammatory drugs

✍ A. Figueras; D. Capellà; J. M. Castel; J. R. Laporte 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 590 KB

Non-steroidal anti-inflammatory drugs (NSAIDs) are the third most commonly prescribed group of drugs in Spain. We present here the profile of adverse drug reactions (ADRs) attributed to them and reported to the Spanish System of Pharmacovigilance (SSPV) between 1983 and 1991, together with a prelimi

Identifying adverse reactions to drugs r

Identifying adverse reactions to drugs reporting systems

✍ Stern, Robert S. 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 780 KB

Using informatics to promote spontaneous

Using informatics to promote spontaneous adverse drug reaction reporting

✍ Ribeiro-Vaz Inês; Santos Cristina; Costa-Pereira Altamiro; Cruz-Correia Ricardo 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 57 KB

Using Facebook to Increase Spontaneous R

Using Facebook to Increase Spontaneous Reporting of Adverse Drug Reactions

✍ Marinela Z. Knezevic, Ivana C. Bivolarevic, Tanja S. Peric, Slobodan M. Jankovic 📂 Article 📅 2011 🏛 Springer International Publishing AG 🌐 English ⚖ 71 KB

Spontaneous reporting of adverse drug re

Spontaneous reporting of adverse drug reactions. II: Uses.

✍ MD Rawlins 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 787 KB

Spontaneous reporting of adverse drug re

Spontaneous reporting of adverse drug reactions: who reports and what?

✍ Pascale Tubert-Bitter; Françoise Haramburu; Bernard Begaud; Anicet Chaslerie; Er 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB

A survey among Bordeaux pharmacovigilance centre `users' and `non-users' was conducted in Aquitaine, France. Two hundred physicians having reported to the centre at least one adverse drug reaction (ADR) during the past 3 years were matched to a randomly selected sample of 400 physicians who did not